Safety Study of RMJH-111b to Treat Essential Hypertension
Phase 1
Completed
- Conditions
- Essential Hypertension
- Interventions
- Drug: Placebo soft gelatin capsuleDrug: Magnesium citrate, tribasic anhydrous soft gelatin capsule
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2020-09-23
- Lead Sponsor
- RMJ Holdings, LLC
- Target Recruit Count
- 22
- Registration Number
- NCT02822222
- Locations
- 🇺🇸
Orange County Research Center, Tustin, California, United States
© Copyright 2025. All Rights Reserved by MedPath